Connect Biopharma Holdings Cash Flow Statement (2024-2025) | CNTB

Cash Flow Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -8.69M14.85M-12.88M-8.91M-10.27M-12.90M-17.20M
Share-based Compensation 1.32M1.99M2.02M1.40M0.94M0.95M0.92M
Gains from Investment Securities 0.00M0.07M0.04M-0.03M0.16M
Cash from Operations -0.59M-7.70M-13.01M-2.32M-9.96M-12.59M-17.41M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.09M0.01M0.02M0.25M0.29M0.17M
Depreciation & Amortization (CF) 0.16M0.16M0.18M0.16M0.17M0.17M0.18M
Change in Working Capital
Change in Receivables 5.02M-4.23M-0.78M-0.01M0.02M
Change in Account Payables -1.84M0.16M-0.15M-0.04M0.47M1.48M-0.30M
Change in Accured Expenses 0.72M-1.30M-0.08M-1.02M-0.56M0.69M1.00M
Other Working Capital Changes -1.21M-0.04M1.49M-2.02M1.29M2.24M1.81M
Investing Activities
Capital Expenditures 0.29M0.15M0.31M0.08M0.30M0.03M
Sales of Property, Plant and Equipment 0.00M
Change in Acquisitions & Divestments 9.25M3.50M2.00M13.34M14.38M
Cash from Investing Activities 9.25M3.21M-0.15M-15.76M-20.64M5.13M14.35M
Financing Activities
Cash from Financing Activities 0.12M0.11M0.00M0.16M0.21M
Additional items
Exchange Rate Effect -0.22M0.10M0.51M-0.98M0.07M0.22M0.06M
Change in Cash 8.44M-4.26M-12.65M-18.96M-30.52M-7.08M-2.79M
Free Cash Flow -0.59M-7.99M-13.15M-2.63M-10.04M-12.89M-17.44M
Net Cash Flow 8.66M-4.36M-13.15M-17.98M-30.60M-7.30M-2.85M